| 2026-08-06 | 10-Q | 10.1 | Offer Letter, by and between Structure Therapeutics USA Inc. and Matt Lang, dated March 17, 2026. |
|---|
| 2026-05-07 | 10-Q | 10.3 | Amended & Restated Participation Agreement under the Structure Therapeutics Inc. Severance and Change in Control Plan, by and between the registrant and Jun Yoon dated April 17, 2026. |
|---|
| 2026-05-07 | 10-Q | 10.2 | Amended & Restated Participation Agreement under the Structure Therapeutics Inc. Severance and Change in Control Plan, by and between the registrant and Raymond Stevens dated April 17, 2026. |
|---|
| 2026-05-07 | 10-Q | 10.1 | Employment Contract, by and between Shanghai ShouTi Biotechnology Co., Ltd. and Yingli Ma, dated May 11, 2024. |
|---|
| 2026-02-26 | 10-K | 10.23 | License Agreement, dated December 30, 2025, by and between Gasherbrum Bio, Inc., Genentech, Inc. and F. Hoffmann-La Roche Ltd. |
|---|
| 2026-02-26 | 10-K | 10.22 | Severance and Change in Control Plan, as amended. |
|---|
| 2026-02-26 | 10-K | 10.17 | Amended Non-Employee Director Compensation Policy. |
|---|
| 2025-11-06 | 10-Q | 10.2 | Severance and Change in Control Plan, as amended. |
|---|
| 2025-11-06 | 10-Q | 10.1 | Executive Employment Agreement, by and between the registrant and Xichen Lin, dated July 22, 2025. |
|---|
| 2025-02-27 | 10-K | 10.19 | Amended Non-Employee Director Compensation Policy. |
|---|
| 2024-11-13 | 10-Q | 10.3 | Offer Letter, dated September 7, 2024, by and between the Registrant and Ashley Hall. |
|---|
| 2024-11-13 | 10-Q | 10.2 | Offer Letter, dated September 12, 2024, by and between the Registrant and Blai Coll. |
|---|
| 2024-11-13 | 10-Q | 10.1 | Separation and Consulting Agreement, dated September 12, 2024, by and between the Registrant and Mark Bach. |
|---|
| 2024-05-09 | 10-Q | 10.2 | Amended Non-Employee Director Compensation Policy. |
|---|
| 2024-05-09 | 10-Q | 10.1 | Executive Employment Agreement, dated July 22, 2022, by and between the registrant and Xichen Lin. |
|---|
| 2023-11-17 | 10-Q | 10.4 | Share Purchase Agreement, dated as of September 29, 2023, by and between Structure Therapeutics Inc. and the purchasers named therein. |
|---|
| 2023-11-14 | 8-K | 10.1 | Collaboration Agreement, dated November 7, 2023, by and between Schrödinger, Inc. and Aconcagua Bio, Inc. |
|---|
| 2023-08-04 | 8-K | 10.1 | Amended Non-Employee Director Compensation Policy. |
|---|
| 2023-07-06 | 8-K | 10.3 | Sublease, by and between Structure Therapeutics USA Inc. and Aligos Therapeutics, Inc., dated June 29, 2023. |
|---|
| 2023-07-06 | 8-K | 10.2 | House Leasing Contract, by and between Shanghai ShouTi Biotechnology Co., Ltd. and Shanghai Chuangzhi Space Entrepreneurship Incubator Management Co., Ltd., dated June 29, 2023. |
|---|
| 2023-07-06 | 8-K | 10.1 | Lease Agreement, by and between the Company and Shanghai Changtai Business Management Co., Ltd., dated June 29, 2023. |
|---|
| 2023-05-11 | 10-Q | 10.1 | Exchange Agreement dated May 10, 2023 between the registrant and the investors named therein |
|---|
| 2023-03-30 | 10-K | 10.9 | Structure Therapeutics Inc. 2023 Employee Share Purchase Plan. |
|---|
| 2023-03-30 | 10-K | 10.3 | Structure Therapeutics Inc. 2023 Equity Incentive Plan. |
|---|